Evidence map›Paper›PMID 40688763›Full record

ArticleLancet regional health. Americas2025

A time-series analysis of the use of opioid medications in a network of Brazilian hospitals, 2009-2020.

Romulo Mendonça Carvalho, Francisco Inácio Bastos, Maria Clara de Magalhães-Barbosa, Lucas Monteiro Bianchi, Jaqueline Rodrigues Robaina, Gustavo Rodrigues-Santos, Antônio José Ledo Alves da Cunha, Arnaldo Prata-Barbosa

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Romulo Mendonça CarvalhoD'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.
Francisco Inácio BastosLaboratory of Health Information, Institute of Scientific and Technological Communication and Information in Health (ICICT), Oswaldo Cruz Foundation (IOC), Rio de Janeiro, RJ, Brazil.
Maria Clara de Magalhães-BarbosaDepartment of Paediatrics, D'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.
Lucas Monteiro BianchiDepartment of Paediatrics, D'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.
Jaqueline Rodrigues RobainaDepartment of Paediatrics, D'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.
Gustavo Rodrigues-SantosDepartment of Paediatrics, D'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.
Antônio José Ledo Alves da CunhaDepartment of Paediatrics, D'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.
Arnaldo Prata-BarbosaDepartment of Paediatrics, D'Or Institute for Research & Education (IDOR), Rio de Janeiro, RJ, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To date, no studies in Brazil have described the profile of hospital opioid use. This study aimed to describe the temporal evolution of opioid consumption in hospitalised patients in a Brazilian hospital network. Methods: This study describes a 12-year time-series (2009-2020) of hospital use of opioids in 28 hospitals of a private network in Brazil. More than four million prescriptions were analyzed using the Findings: Parenteral tramadol was the most consumed opioid, followed by parenteral fentanyl and parenteral morphine. Among enteral opioids, the most commonly used was codeine followed by tramadol. There were several variations in the use patterns for most medications, with periods of significant increases and decreases, but two opioids underwent considerable change: parenteral fentanyl, which doubled in consumption, especially during the COVID-19 pandemic, and enteral tramadol, which had a fourfold reduction over time. Enteral oxycodone, the pivot of the opioid crisis in the USA, was relatively little used in this series. Methadone, both parenteral and enteral, was seldom used at the hospitals under analysis, an indicator of a mild use of other opioids, before and/or during hospitalisation. Interpretation: Knowledge and documentation of the utilisation profile of this class of medication is relevant, given the concern that any increase in consumption at any point in the chain, including during hospitalisations, may trigger events of increased outpatient opioid use and potential misuse. Funding: Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ, grant E-26/010.002428/2019) and IDORDepartment of Pediatrics, Rio de Janeiro, RJ, Brazil.

Indexed as

Drug prescriptionOpioid analgesicsTime series analysis

Identifiers

PMID40688763
PMCPMC12273242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.